By Mitchell Labiak2019-03-04T12:43:00
The European Medicines Agency (EMA) has been given permission to appeal the High Court’s decision against it last month.
Permission for the case to be heard at the Court of Appeal was granted on all grounds. It will be heard at the Court of Appeal and is on the question of whether Brexit amounts to the ‘frustration’ of the European Medicines Agency’s 25-year, £500m lease at Canary Wharf.
You must be logged in to continue
Register for free to finish this article
Registration includes the following benefits:
To access this article REGISTER NOW
Four articles not enough? SUBSCRIBE for unlimited access to over 100 weekly articles and our comprehensive archive. For as little as £5 per week.